CommentaryPublished 27 January 2026Commentary: CVM-1118 (foslinanib), a 2-phenyl-4-quinolone derivative, promotes apoptosis and inhibits vasculogenic mimicry via targeting TRAP1Mary J. C. Hendrix · Elisabeth A. Seftor · Richard E. B. Seftor · Yi-Wen Chu · Du-Shieng Chien · Yen-Ling ChenPathology and Oncology Researchdoi 10.3389/pore.2026.1612325